{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:00:03Z","timestamp":1788872403974,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["HL-68880"],"award-info":[{"award-number":["HL-68880"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Telethon Italy","award":["GGP07016"],"award-info":[{"award-number":["GGP07016"]}]},{"name":"Telethon Italy","award":["GGP09247"],"award-info":[{"award-number":["GGP09247"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.pharmthera.2011.03.001","type":"journal-article","created":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T14:59:40Z","timestamp":1300287580000},"page":"171-177","source":"Crossref","is-referenced-by-count":16,"title":["Pharmacological and non-pharmacological management of the congenital long QT syndrome: The rationale"],"prefix":"10.1016","volume":"131","author":[{"given":"Peter J.","family":"Schwartz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2011.03.001_bb0005","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/j.athoracsur.2008.07.006","article-title":"Video-assisted thorascopic cardiac denervation: a potential novel therapeutic option for children with intractable ventricular arrhythmias","volume":"86","author":"Atallah","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.pharmthera.2011.03.001_bb0010","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/376683a0","article-title":"Molecular mechanism for an inherited cardiac arrhythmia","volume":"376","author":"Bennett","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2011.03.001_bb0015","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.hrthm.2009.03.024","article-title":"Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery","volume":"6","author":"Collura","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.pharmthera.2011.03.001_bb0020","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jacc.2007.05.042","article-title":"Long QT syndrome in children in the era of implantable defibrillators","volume":"50","author":"Etheridge","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2011.03.001_bb0025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0002-8703(57)90079-0","article-title":"Congenital deaf-mutism, functional heart disease with prolongation of the Q\u2013T interval, and sudden death","volume":"54","author":"Jervell","year":"1957","journal-title":"Am Heart J"},{"key":"10.1016\/j.pharmthera.2011.03.001_bb0030","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1161\/01.CIR.101.6.616","article-title":"Effectiveness and limitations of \u03b2-blocker therapy in congenital long-QT syndrome","volume":"101","author":"Moss","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2011.03.001_bb0035","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.hrthm.2010.03.046","article-title":"Left cardiac sympathetic denervation for the prevention of life-threatening arrhythmias. The surgical supraclavicular approach to cervico-thoracic sympathectomy","volume":"7","author":"Odero","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.pharmthera.2011.03.001_bb0040","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1001\/jama.292.11.1341","article-title":"Association of long QT syndrome loci and cardiac events among patients treated with \u03b2-blockers","volume":"292","author":"Priori","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2011.03.001_bb0045","first-page":"656","article-title":"Aritmie cardiache rare dell'et\u00e0 pediatrica","volume":"45","author":"Romano","year":"1963","journal-title":"Clin Pediatr"},{"key":"10.1016\/j.pharmthera.2011.03.001_bb0050","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1749-6632.1984.tb20785.x","article-title":"The rationale and the role of left stellectomy for the prevention of malignant arrhythmias","volume":"427","author":"Schwartz","year":"1984","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.pharmthera.2011.03.001_bb0055","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2796.2005.01583.x","article-title":"The congenital long QT syndromes from genotype to phenotype: clinical implications","volume":"259","author":"Schwartz","year":"2006","journal-title":"J Intern Med"},{"key":"10.1016\/j.pharmthera.2011.03.001_bb0060","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.hrthm.2009.04.009","article-title":"Cutting nerves and saving lives","volume":"6","author":"Schwartz","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.pharmthera.2011.03.001_bb0065","series-title":"Novel Therapeutic Targets for Antiarrhythmic Drugs","first-page":"495","article-title":"Non-pharmacologic manipulation of the autonomic nervous system in humans for the prevention of life-threatening arrhythmias","author":"Schwartz","year":"2010"},{"key":"10.1016\/j.pharmthera.2011.03.001_bb0070","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.hrthm.2010.04.038","article-title":"Efficacy of left cardiac sympathetic denervation has an unforeseen side effect: medicolegal complications","volume":"7","author":"Schwartz","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.pharmthera.2011.03.001_bb0075","doi-asserted-by":"crossref","unstructured":"Schwartz P. J. (in press). Genetic diseases: The long QT syndrome. In S. Saksena, A. J. Camm, (Eds.), Electrophysiological Disorders of the Heart. II Edition. Philadelphia: Elsevier Churchill Livingstone.","DOI":"10.1016\/B978-1-4377-0285-9.00064-8"},{"key":"10.1016\/j.pharmthera.2011.03.001_bb0080","series-title":"Cardiac Electrophysiology: From Cell to Bedside","first-page":"731","article-title":"Long QT and short QT syndromes","author":"Schwartz","year":"2009"},{"issue":"Suppl. D","key":"10.1016\/j.pharmthera.2011.03.001_bb0085","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/eurheartj\/6.suppl_D.103","article-title":"The idiopathic long QT syndrome. Pathogenetic mechanisms and therapy","volume":"6","author":"Schwartz","year":"1985","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2011.03.001_bb0095","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1540-8167.1992.tb01090.x","article-title":"Prevention of sudden cardiac death after a first myocardial infarction by pharmacologic or surgical antiadrenergic interventions","volume":"3","author":"Schwartz","year":"1992","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.pharmthera.2011.03.001_bb0100","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/0002-8703(75)90089-7","article-title":"The long Q\u2013T syndrome","volume":"89","author":"Schwartz","year":"1975","journal-title":"Am Heart J"},{"key":"10.1016\/j.pharmthera.2011.03.001_bb0105","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1161\/01.CIR.0000125523.14403.1E","article-title":"Left cardiac sympathetic denervation in the management of high-risk patients affected by the long QT syndrome","volume":"109","author":"Schwartz","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2011.03.001_bb0110","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1161\/01.CIR.92.12.3381","article-title":"Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy","volume":"92","author":"Schwartz","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2011.03.001_bb0115","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/01.CIR.103.1.89","article-title":"Genotype\u2013phenotype correlation in the long QT syndrome. Gene-specific triggers for life-threatening arrhythmias","volume":"103","author":"Schwartz","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2011.03.001_bb0120","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/0002-9149(76)90420-3","article-title":"Effects of unilateral cardiac sympathetic denervation on the ventricular fibrillation threshold","volume":"37","author":"Schwartz","year":"1976","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2011.03.001_bb0175","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0002-8703(76)80078-6","article-title":"Effects of unilateral stellate ganglion blockade on the arrhythmias associated with coronary occlusion","volume":"92","author":"Schwartz","year":"1976","journal-title":"Am Heart J"},{"key":"10.1016\/j.pharmthera.2011.03.001_bb0125","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.hrthm.2008.10.017","article-title":"All LQT3 patients need an ICD. True or false?","volume":"6","author":"Schwartz","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.pharmthera.2011.03.001_bb0130","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1161\/CIRCULATIONAHA.105.592899","article-title":"The Jervell and Lange-Nielsen syndrome. Natural history, molecular basis, and clinical outcome","volume":"113","author":"Schwartz","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2011.03.001_bb0135","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1161\/CIRCULATIONAHA.110.950147","article-title":"Who are the long-QT syndrome patients who receive an implantable cardioverter defibrillator and what happens to them? Data from the European long-QT syndrome implantable cardioverter-defibrillator (LQTS ICD) registry","volume":"122","author":"Schwartz","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2011.03.001_bb0140","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1161\/CIRCULATIONAHA.109.863209","article-title":"Prevalence of the congenital long-QT syndrome","volume":"120","author":"Schwartz","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2011.03.001_bb0145","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1161\/CIRCULATIONAHA.108.772533","article-title":"High efficacy of \u03b2-blockers in long QT syndrome type 1: contribution of non-compliance and QT prolonging drugs to the occurrence of \u03b2-blocker treatment \u201cfailures\u201d","volume":"119","author":"Vincent","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2011.03.001_bb0150","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/CIRCEP.108.788349","article-title":"Malignant perinatal variant of long QT syndrome caused by a profoundly dysfunctional cardiac sodium channel","volume":"1","author":"Wang","year":"2008","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"10.1016\/j.pharmthera.2011.03.001_bb0155","first-page":"103","article-title":"A new familial cardiac syndrome in children","volume":"54","author":"Ward","year":"1964","journal-title":"J Ir Med Assoc"},{"key":"10.1016\/j.pharmthera.2011.03.001_bb0160","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1056\/NEJMoa0708006","article-title":"Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia","volume":"358","author":"Wilde","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2011.03.001_bb0165","first-page":"S43","article-title":"Electrical storm in children with an implantable cardioverter defibrillator: clinical features and outcome","volume":"4","author":"Wolf","year":"2007","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.pharmthera.2011.03.001_bb0170","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1540-8167.2003.02545.x","article-title":"Implantable cardioverter defibrillator in high-risk long QT syndrome patients","volume":"14","author":"Zareba","year":"2003","journal-title":"J Cardiovasc Electrophysiol"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725811000556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725811000556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T19:27:19Z","timestamp":1543865239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725811000556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0163725811000556"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2011.03.001","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}